Company: THC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0000070318-25-000039
Chunk: 24

Company: TENET HEALTHCARE CORP
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 1
Chunk 24
---
267 $2.66 Effect of dilutive instruments1 1,177 (0.02)Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share$260 98,444 $2.64 Six Months Ended June 30, 2025   Net income available to Tenet Healthcare Corporation common shareholders for basic earnings per share$694 92,688 $7.49 Effect of dilutive instruments— 720 (0.06)Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share$694 93,408 $7.43 Six Months Ended June 30, 2024   Net income available to Tenet Healthcare Corporation common shareholders for basic earnings per share$2,410 98,424 $24.49 Effect of dilutive instruments1 1,133 (0.27)Net income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share$2,411 99,557 $24.22 Dilutive instruments during the three and six months ended June 30, 2025 and 2024 consisted of stock options, RSUs, deferred compensation units and dividends on subsidiary preferred stock. During the six-month period in 2024, our dilutive instruments also included RSUs issued under USPI’s restricted stock plan.

NOTE 15. FAIR VALUE MEASUREMENTS 

We are required to provide additional disclosures about fair value measurements as part of our financial statements for each major category of assets and liabilities measured at fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities, which generally are not applicable to non‑financial assets and liabilities. Fair values determined by Level 2 inputs utilize data points that are observable, such as definitive sales agreements, appraisals or established market values of comparable assets. Fair values determined by Level 3 inputs utilize unobservable data points for the asset or liability and include situations where there is little, if any, market activity for the asset or liability, such as internal estimates of future cash flows.Financial InstrumentsThe fair value of our long‑term debt (except for borrowings under the Credit Agreement) is based on quoted market prices (Level 1). The inputs used to establish the fair value of the borrowings outstanding under the Credit Agreement are considered to be Level 2 inputs. At June 30, 2025 and